Physician profile
John Thomas Raabe
NPI 1770606717
$1,973.82
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $49.22 · 2022: $14.68 · 2023: $1,881 · 2024: $29.12.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Gift: $1,743 · Food and Beverage: $142 · Education: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Gift | $1,743.17 |
| Food and Beverage | $141.75 |
| Education | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ultradent Products INC | $1,743.17 | 2023 | Opalescence |
| Nobel Biocare USA | $67.25 | 2019-2023 | Nobelactive |
| Biolase, INC. | $48.26 | 2023 | Waterlase Iplus |
| Zimvie INC. | $39.18 | 2023 | |
| Hu-Friedy Mfg. Co., LLC | $25.00 | 2023 | |
| Dentsply Ih INC. | $21.84 | 2019 | |
| Solventum Corporation | $16.61 | 2024 | Clinpro 5000, 3m Relyx, 3m Espe Filtek Supreme Ultra Universal Restorative |
| Dmg America LLC | $12.51 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Raabe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.